Dr. Siddiqui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
419 West Redwood Street
Suite 320
Baltimore, MD 21201Phone+1 410-328-6422Fax+1 410-328-0595
Summary
- Dr. Siddiqui is dedicated to providing the highest quality, cutting-edge care to his patients while minimizing the impact that treatment has on their quality of life. He utilizes the DaVinci robot when appropriate for his surgical procedures, but he also values the opinion that in cases when a disease can be managed without surgery (such as with active surveillance) or with minimal intervention such as with focal therapy or bladder sparing protocol, this may be the best option for the patient.
Dr. Siddiqui maintains active research interests in discovering better ways to differentiate aggressive prostate cancer from non-aggressive cancer using cell metabolism and MRI imaging. His ultimate goal is to not only improve the confidence with which physicians can identify cancer in the prostate, but also find ways to reliably differentiate, using non-noninvasive approaches, whether that cancer is aggressive and needs treatment, or clinically insignificant and can be watched carefully without the need for any further treatment or surgery.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2012 - 2014
- Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 2006 - 2012
- Harvard Medical SchoolClass of 2006, MD
- Massachusetts Institute of TechnologyBS, Chemical Engineering, 1997 - 2001
Certifications & Licensure
- MD State Medical License 2012 - 2025
- DC State Medical License 2013 - 2014
- MA State Medical License 2012 - 2014
- American Board of Urology Urology
Clinical Trials
- Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy Start of enrollment: 2014 May 31
Publications & Presentations
PubMed
- 30 citationsMetabolic targets for potential prostate cancer therapeutics.Jeffrey Twum-Ampofo, Dexue Fu, Antonino Passaniti, Arif Hussain, M. Minhaj Siddiqui
Current Opinion in Oncology. 2016-05-01 - 450 citationsThe use of whole organ decellularization for the generation of a vascularized liver organoidPedro M. Baptista, M. Minhaj Siddiqui, Genevieve Lozier, Sergio Rodriguez, Anthony Atala
Hepatology. 2011-02-01 - 1128 citationsComparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate CancerM. Minhaj Siddiqui, Soroush Rais-Bahrami, Baris Turkbey, Arvin K. George, Jason Rothwax
JAMA. 2015-01-27
Press Mentions
- ODAC Votes to Keep Keytruda and Tecentriq Accelerated Approvals in Bladder CancerApril 28th, 2021
- UMSOM Doctor Joins National Prostate Cancer StudySeptember 23rd, 2019
- Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer StudySeptember 23rd, 2019
- Join now to see all
External Links
- University of Maryland Medical Schoolhttp://medschool.umaryland.edu/FACULTYRESEARCHPROFILE/viewprofile.aspx?id=28551
- University of Maryland Medical Centerhttp://findadoctor.umm.edu/Details/24740
- University of Maryland Greenebaum Cancer Centerhttp://www.umgcc.org/news/mohummad_minhaj_siddiqui.htm
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: